An interventional study of Femoral Intramedullary Nail and OrthoXel Micromotion Nailing System in Femoral Shaft Fracture, sponsored by Indiana University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Indiana University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
A randomized controlled trial that is trying to find the best treatment for a severe upper leg (i.e., thigh, also known as femoral shaft) fracture. One type of treatment, which is called micromotion intramedullary (within the hollow center of the bone) nailing, is a type of nail used for thigh fracture treatments that helps to heal the bone by allowing a small amount of controlled movement. Another type, called non-micromotion intramedullary nailing, is also used to treat thigh fractures but does not include this controlled-movement feature. Both treatments are approved by the FDA but have not been directly compared to each other. Participation includes being assigned to receive either a micromotion intramedullary nail or a non-micromotion intramedullary nail. Those that participate will be randomly assigned (like a flip of a coin) to one of those treatment methods and return for standard follow-up visits. In addition to those regular clinical follow-ups, participants will complete some brief surveys/questionnaires while they are in the hospital. Research staff will also look at past medical history.
Indiana University is the lead sponsor of 990 studies on the registry; 201 are open to participants now.
Of its 150 completed or terminated interventional studies of FDA-regulated products, 118 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Femoral Intramedullary Nail
Device: OrthoXel Micromotion Nailing System
A rod inserted into the hollow center of a long bone to hold a broken bone in place while it heals.
An intramedullary nail that allows for controlled axial micromotion.
Superiority of micromotion nailing over non-micromotion IMN according to a composite outcome using a win ratio reflective of improved femoral shaft fracture healing
Time frame: From enrollment to end of treatment at about a year.
Iindividual levels of the win-ratio pyramid between the micromotion nailing and non-micromotion nailing groups.
Time frame: From enrollment to end of treatment at about a year.
Superiority of micromotion nailing in a subgroup of patients at high baseline risk for nonunion.
Time frame: From enrollment to end of treatment at about a year.
Number of patients with Adverse Events and Complications between the Micromotion nail and standard of care intramedullary nails.
Time frame: From enrollment to end of treatment at about a year.
Change in daily step count from pre-injury baseline between the micromotion nailing and non-micromotion nailing groups.
Daily step count, measured in steps per day, will be obtained from the Apple Health app on the participant's iPhone. Participants will download the OrthoSteps app once to transfer their Apple Health data to the study team. Step counts will be assessed at the pre-injury baseline and at each post-injury follow-up.
Time frame: From enrollment to end of treatment at about a year.
Gait balance between the two groups as calculated by the GaitMap.
Time frame: From enrollment to end of treatment at about a year
Walking speed using a GaitMap
Time frame: From enrollment to end of treatment at about a year.
Modified Radiographic union scores for femoral shaft fractures
Time frame: From enrollment to end of treatment at about a year.
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Sep 2031, 60 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.